Patent · US Active

Method of treatment comprising purified recombinant IL-13 antibody

US10597446B2 · kind B2 · utility

9Cited by

74References

21Claims

0Family size

Assignee

Genentech, Inc. · US

Inventors

X. Christopher Yu · Piedmont, US
Saloumeh Kadkhodayan Fischer · Castro Valley, US
Susan C. Fisher · Redwood City, US
John Lowe · Daly City, US
Ailen Sanchez · Foster City, US
Martin Vanderlaan · San Francisco, US

Key dates

Filing date	Feb 1, 2018
Grant date	Mar 24, 2020
Priority date	—
Expiry date	Feb 1, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/565
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Purified recombinant polypeptides isolated from Chinese hamster ovary host cells, including antibodies, such as therapeutic antibodies, and methods of making and using such polypeptides are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.